Rates and associates of influenza and pneumococcus vaccination in diabetes mellitus: A nationwide cross-sectional study (TEMD vaccination study).

Diabetes Influenza Pneumococcus Type 1 diabetes Type 2 diabetes Vaccination

Journal

World journal of diabetes
ISSN: 1948-9358
Titre abrégé: World J Diabetes
Pays: United States
ID NLM: 101547524

Informations de publication

Date de publication:
15 Dec 2021
Historique:
received: 12 05 2021
revised: 13 07 2021
accepted: 24 11 2021
entrez: 20 1 2022
pubmed: 21 1 2022
medline: 21 1 2022
Statut: ppublish

Résumé

Vaccination against influenza and pneumococcus is effective in reducing morbidity and mortality in patients with diabetes. To investigate the prevalence of influenza and pneumococcal vaccinations and to search for the independent associates of vaccination in Turkish patients with diabetes. In this cross-sectional, nationwide, multicenter study, adult patients with type 1 diabetes (T1DM) ( Patients with T1DM and T2DM had similar vaccination rates for influenza (23.6% TEMD Vaccination Study shows that patients with T1DM and T2DM had very low influenza and pneumococcal vaccination rates in Turkey. The lower rates of vaccination in certain populations urges the necessity of nationwide vaccination strategies targeting these populations.

Sections du résumé

BACKGROUND BACKGROUND
Vaccination against influenza and pneumococcus is effective in reducing morbidity and mortality in patients with diabetes.
AIM OBJECTIVE
To investigate the prevalence of influenza and pneumococcal vaccinations and to search for the independent associates of vaccination in Turkish patients with diabetes.
METHODS METHODS
In this cross-sectional, nationwide, multicenter study, adult patients with type 1 diabetes (T1DM) (
RESULTS RESULTS
Patients with T1DM and T2DM had similar vaccination rates for influenza (23.6%
CONCLUSION CONCLUSIONS
TEMD Vaccination Study shows that patients with T1DM and T2DM had very low influenza and pneumococcal vaccination rates in Turkey. The lower rates of vaccination in certain populations urges the necessity of nationwide vaccination strategies targeting these populations.

Identifiants

pubmed: 35047124
doi: 10.4239/wjd.v12.i12.2107
pmc: PMC8696642
doi:

Types de publication

Journal Article

Langues

eng

Pagination

2107-2118

Informations de copyright

©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.

Déclaration de conflit d'intérêts

Conflict-of-interest statement: There is no conflict of interest.

Références

Diabetes Care. 2021 Jan;44(Suppl 1):S40-S52
pubmed: 33298415
CMAJ. 2016 Oct 4;188(14):E342-E351
pubmed: 27455981
Vaccines (Basel). 2020 Sep 24;8(4):
pubmed: 32987794
Diabet Med. 2005 Jan;22(1):110-1
pubmed: 15606702
Ann Intern Med. 2006 Apr 4;144(7):465-74
pubmed: 16585660
Hum Vaccin Immunother. 2013 Jun;9(6):1326-32
pubmed: 23403458
Ann Intern Med. 2009 May 5;150(9):604-12
pubmed: 19414839
Infect Chemother. 2015 Mar;47(1):41-8
pubmed: 25844262
Am J Public Health. 1999 Nov;89(11):1715-21
pubmed: 10553394
Vaccine. 2017 Feb 7;35(6):889-896
pubmed: 28094076
World Health Organ Tech Rep Ser. 2000;894:i-xii, 1-253
pubmed: 11234459
PLoS One. 2017 Jan 26;12(1):e0170550
pubmed: 28125629
Diabetes Res Clin Pract. 2018 Dec;146:138-147
pubmed: 30244051
Infect Dis Clin North Am. 1995 Mar;9(1):65-96
pubmed: 7769221
Diabetes Care. 2004 Nov;27(11):2581-4
pubmed: 15504989
Vaccine. 2020 Sep 3;38(39):6078-6079
pubmed: 32773245
Prev Med. 2012 May;54(5):358-62
pubmed: 22465670
Hum Vaccin Immunother. 2013 Dec;9(12):2618-26
pubmed: 23887188
Hum Vaccin Immunother. 2021 Jul 3;17(7):2169-2175
pubmed: 33377817
Vaccine. 2003 Mar 28;21(13-14):1510-7
pubmed: 12615448
Diabetes Res Clin Pract. 1991 Apr;12(1):61-8
pubmed: 1906798
MMWR Morb Mortal Wkly Rep. 2020 Feb 07;69(5):133-135
pubmed: 32027627
J Clin Transl Endocrinol. 2020 May 11;20:100227
pubmed: 32395432
Diabetes Res Clin Pract. 2008 Mar;79(3):510-7
pubmed: 18035444
Diabet Med. 1997 Jan;14(1):29-34
pubmed: 9017350
Diabetes Metab. 2020 Apr;46(2):137-143
pubmed: 31255692
Diabetes Care. 2006 Aug;29(8):1771-6
pubmed: 16873778
Pharm Pract (Granada). 2014 Apr;12(2):410
pubmed: 25035719

Auteurs

Ibrahim Demirci (I)

Department of Endocrinology and Metabolism, Gulhane Training and Research Hospital, Ankara 06190, Turkey.

Cem Haymana (C)

Department of Endocrinology and Metabolism, Gulhane Training and Research Hospital, Ankara 06190, Turkey.

Serpil Salman (S)

Department of Endocrinology and Metabolism, Liv Hospital, Istanbul 34000, Turkey.

Ilker Tasci (I)

Department of Internal Medicine, University of Health Sciences, Gulhane Faculty of Medicine, Ankara 06018, Turkey.

Demet Corapcioglu (D)

Department of Endocrinology and Metabolism, Ankara University, Faculty of Medicine, Ankara 06560, Turkey.

Ali Kirik (A)

Department of Internal Medicine, Balıkesir University, Faculty of Medicine, Balikesir 10145, Turkey.

İlhan Yetkin (İ)

Department of Endocrinology and Metabolism, Gazi University, Faculty of Medicine, Ankara 06190, Turkey.

Mustafa Altay (M)

Department of Endocrinology and Metabolism, Kecioren Training and Research Hospital, Ankara 06190, Turkey. mustafa.altay@sbu.edu.tr.

Tevfik Sabuncu (T)

Department of Endocrinology and Metabolism, Harran University, Faculty of Medicine, Sanliurfa 63050, Turkey.

Fahri Bayram (F)

Department of Endocrinology and Metabolism, Erciyes University, Faculty of Medicine, Kayseri 38000, Turkey.

Ilhan Satman (I)

Department of Endocrinology and Metabolism, Istanbul University, Faculty of Medicine, Istanbul 34000, Turkey.

Alper Sonmez (A)

Department of Endocrinology and Metabolism, University of Health Sciences, Gulhane Faculty of Medicine, Ankara 06190, Turkey.

Classifications MeSH